Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Jan;51(1):61–66. doi: 10.1136/ard.51.1.61

Antibodies to histones in systemic lupus erythematosus: prevalence, specificity, and relationship to clinical and laboratory features.

M G Cohen 1, K M Pollard 1, J Webb 1
PMCID: PMC1004620  PMID: 1540040

Abstract

Antibodies to histones (AHA) are commonly found in patients with systemic lupus erythematosus (SLE). However, the full profile of AHA and their clinical associations remains unclear. A total of 111 patients with SLE were studied, including 13 patients in whom multiple serum samples were available over several years. IgM, IgG, and IgA antibodies to total core histones, histone complexes, and individual histones were determined by highly sensitive enzyme linked immunosorbent assays (ELISAs). Antibodies to histones were detected in 74% of serum samples, though only at low levels in half of these. Antibodies to each of the individual histones (H1, H2A, H2B, H3, H4) occurred with similar frequencies except for IgG and IgA antibodies to H4, which were uncommon. In contrast, antibodies to the histone complexes H2A-H2B and H3-H4 were detected in only two serum samples and thus do not appear to be a feature of SLE. All three major isotypes of AHA were common and usually occurred with similar frequencies to one another for the various histone specificities. There were few clinical or laboratory associations with AHA; the strongest was between IgG antibodies to total core histones and antibodies to native DNA. Similarly, there was no association between the presence of AHA and disease activity. However, for the patients as a group and in one patient alone, periods of SLE disease activity were associated with higher levels of AHA. Although the profile of antibodies to individual histones varied with time, no profile was identified that corresponded with any specific disease manifestations. It is concluded from this study that although AHA are common in patients with SLE, their clinical value in this syndrome must, at present, be considered limited.

Full text

PDF
61

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S. G., Wang H., Ward H. J., Cohen A. H., Border W. A. Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit. J Clin Invest. 1983 Mar;71(3):487–499. doi: 10.1172/JCI110793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernstein R. M., Hobbs R. N., Lea D. J., Ward D. J., Hughes G. R. Patterns of antihistone antibody specificity in systemic rheumatic disease. I Systemic lupus erythematosus, mixed connective tissue disease, primary sicca syndrome, and rheumatoid arthritis with vasculitis. Arthritis Rheum. 1985 Mar;28(3):285–293. doi: 10.1002/art.1780280308. [DOI] [PubMed] [Google Scholar]
  3. Boey M. L., Peebles C. L., Tsay G., Feng P. H., Tan E. M. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus. Ann Rheum Dis. 1988 Nov;47(11):918–923. doi: 10.1136/ard.47.11.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burlingame R. W., Love W. E., Wang B. C., Hamlin R., Nguyen H. X., Moudrianakis E. N. Crystallographic structure of the octameric histone core of the nucleosome at a resolution of 3.3 A. Science. 1985 May 3;228(4699):546–553. doi: 10.1126/science.3983639. [DOI] [PubMed] [Google Scholar]
  5. Bustin M., Reisch J., Einck L., Klippel J. H. Autoantibodies to nucleosomal proteins: antibodies to HMG-17 in autoimmune diseases. Science. 1982 Mar 5;215(4537):1245–1247. doi: 10.1126/science.6460317. [DOI] [PubMed] [Google Scholar]
  6. Böhm E. L., Strickland W. N., Strickland M., Thwaits B. H., van der Westhuizen D. R., von Holt C. Purification of the five main calf thymus histone fractions by gel exclusion chromatography. FEBS Lett. 1973 Aug 15;34(2):217–221. doi: 10.1016/0014-5793(73)80797-5. [DOI] [PubMed] [Google Scholar]
  7. Cohen M. G., Kevat S., Prowse M. V., Ahern M. J. Two distinct quinidine-induced rheumatic syndromes. Ann Intern Med. 1988 Mar;108(3):369–371. doi: 10.7326/0003-4819-108-3-369. [DOI] [PubMed] [Google Scholar]
  8. Cohen M. G., Webb J. Antihistone antibodies in rheumatoid arthritis and Felty's syndrome. Arthritis Rheum. 1989 Oct;32(10):1319–1324. doi: 10.1002/anr.1780321020. [DOI] [PubMed] [Google Scholar]
  9. Costa O., Monier J. C. Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 1986 Aug;13(4):722–725. [PubMed] [Google Scholar]
  10. Costa O., Tchouatcha-Tchouassom J. C., Roux B., Monier J. C. Anti-H1 histone antibodies in systemic lupus erythematosus: epitope localization after immunoblotting of chymotrypsin-digested H1. Clin Exp Immunol. 1986 Mar;63(3):608–613. [PMC free article] [PubMed] [Google Scholar]
  11. Craft J. E., Radding J. A., Harding M. W., Bernstein R. M., Hardin J. A. Autoantigenic histone epitopes: a comparison between procainamide- and hydralazine-induced lupus. Arthritis Rheum. 1987 Jun;30(6):689–694. doi: 10.1002/art.1780300612. [DOI] [PubMed] [Google Scholar]
  12. Epstein A., Greenberg M., Halbert S., Kramer L., Barland P. The clinical application of an ELISA technique for the detection of antihistone antibodies. J Rheumatol. 1986 Apr;13(2):304–307. [PubMed] [Google Scholar]
  13. Fishbein E., Alarcon-Segovia D., Vega J. M. Antibodies to histones in systemic lupus erythematosus. Clin Exp Immunol. 1979 Apr;36(1):145–150. [PMC free article] [PubMed] [Google Scholar]
  14. Fritzler M., Ryan P., Kinsella T. D. Clinical features of systemic lupus erythematosus patients with antihistone antibodies. J Rheumatol. 1982 Jan-Feb;9(1):46–51. [PubMed] [Google Scholar]
  15. Gallo G. R., Caulin-Glaser T., Lamm M. E. Charge of circulating immune complexes as a factor in glomerular basement membrane localization in mice. J Clin Invest. 1981 May;67(5):1305–1313. doi: 10.1172/JCI110159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gioud M., Kaci M. A., Monier J. C. Histone antibodies in systemic lupus erythematosus. A possible diagnostic tool. Arthritis Rheum. 1982 Apr;25(4):407–413. doi: 10.1002/art.1780250408. [DOI] [PubMed] [Google Scholar]
  17. Gohill J., Cary P. D., Couppez M., Fritzler M. J. Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol. 1985 Nov;135(5):3116–3121. [PubMed] [Google Scholar]
  18. Gompertz N. R., Isenberg D. A., Turner B. M. Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes. Ann Rheum Dis. 1990 Jul;49(7):524–527. doi: 10.1136/ard.49.7.524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gripenberg M., Helve T., Kurki P. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA. J Rheumatol. 1985 Oct;12(5):934–939. [PubMed] [Google Scholar]
  20. Harmon C. E., Portanova J. P. Drug-induced lupus: clinical and serological studies. Clin Rheum Dis. 1982 Apr;8(1):121–135. [PubMed] [Google Scholar]
  21. Helve T., Gripenberg M., Kurki P., Teppo A. M., Wegelius O. Enzyme-linked immunosorbent assays for antibodies to poly(A), poly dAT and histones: possibly useful tools for the evaluation of prognosis and disease activity in systemic lupus erythematosus. Rheumatol Int. 1984;4(2):75–78. doi: 10.1007/BF00541200. [DOI] [PubMed] [Google Scholar]
  22. Konstantinov K., Russanova V., Russeva V. Antibodies to histones and disease activity in systemic lupus erythematosus: a comparative study with an enzyme-linked immunosorbent assay and immunoblotting. Arch Dermatol Res. 1986;278(5):410–415. doi: 10.1007/BF00418172. [DOI] [PubMed] [Google Scholar]
  23. Krippner H., Springer B., Merle S., Pirlet K. Antibodies to histones of the IgG and IgM class in systemic lupus erythematosus. Clin Exp Immunol. 1984 Oct;58(1):49–56. [PMC free article] [PubMed] [Google Scholar]
  24. Laskov R., Muller S., Hochberg M., Giloh H., Van Regenmortel M. H., Eilat D. Monoclonal autoantibodies to histones from autoimmune NZB/NZW F1 mice. Eur J Immunol. 1984 Jan;14(1):74–81. doi: 10.1002/eji.1830140114. [DOI] [PubMed] [Google Scholar]
  25. Meyer O., Cyna L., Haïm T., Ryckewaert A. Les anticorps anti-histones de type IgG. Valeur diagnostique au cours de la polyarthrite rhumatoïde, de la sclérodermie, de la maladie lupique spontanée et médicamenteuse. Rev Rhum Mal Osteoartic. 1984 Jun;51(6):303–310. [PubMed] [Google Scholar]
  26. Muller S., Bonnier D., Thiry M., Van Regenmortel M. H. Reactivity of autoantibodies in systemic lupus erythematosus with synthetic core histone peptides. Int Arch Allergy Appl Immunol. 1989;89(2-3):288–296. doi: 10.1159/000234962. [DOI] [PubMed] [Google Scholar]
  27. Portanova J. P., Arndt R. E., Tan E. M., Kotzin B. L. Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions. J Immunol. 1987 Jan 15;138(2):446–451. [PubMed] [Google Scholar]
  28. Portanova J. P., Rubin R. L., Joslin F. G., Agnello V. D., Tan E. M. Reactivity of anti-histone antibodies induced by procainamide and hydralazine. Clin Immunol Immunopathol. 1982 Oct;25(1):67–79. doi: 10.1016/0090-1229(82)90166-0. [DOI] [PubMed] [Google Scholar]
  29. Rubin R. L., Joslin F. G., Tan E. M. Specificity of anti-histone antibodies in systemic lupus erythematosus. Arthritis Rheum. 1982 Jul;25(7):779–782. doi: 10.1002/art.1780250712. [DOI] [PubMed] [Google Scholar]
  30. Rubin R. L., McNally E. M., Nusinow S. R., Robinson C. A., Tan E. M. IgG antibodies to the histone complex H2A-H2B characterize procainamide-induced lupus. Clin Immunol Immunopathol. 1985 Jul;36(1):49–59. doi: 10.1016/0090-1229(85)90038-8. [DOI] [PubMed] [Google Scholar]
  31. Rubin R. L., Waga S. Antihistone antibodies in systemic lupus erythematosus. J Rheumatol Suppl. 1987 Jun;14 (Suppl 13):118–126. [PubMed] [Google Scholar]
  32. Rumore P. M., Steinman C. R. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest. 1990 Jul;86(1):69–74. doi: 10.1172/JCI114716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schmiedeke T. M., Stöckl F. W., Weber R., Sugisaki Y., Batsford S. R., Vogt A. Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med. 1989 Jun 1;169(6):1879–1894. doi: 10.1084/jem.169.6.1879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shoenfeld Y., Segol G., Segol O., Neary B., Klajman A., Stollar B. D., Isenberg D. A. Detection of antibodies to total histones and their subfractions in systemic lupus erythematosus patients and their asymptomatic relatives. Arthritis Rheum. 1987 Feb;30(2):169–175. doi: 10.1002/art.1780300207. [DOI] [PubMed] [Google Scholar]
  35. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  36. Thomas J. O., Wilson C. M., Hardin J. A. The major core histone antigenic determinants in systemic lupus erythematosus are in the trypsin-sensitive regions. FEBS Lett. 1984 Apr 9;169(1):90–96. doi: 10.1016/0014-5793(84)80295-1. [DOI] [PubMed] [Google Scholar]
  37. Totoritis M. C., Tan E. M., McNally E. M., Rubin R. L. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med. 1988 Jun 2;318(22):1431–1436. doi: 10.1056/NEJM198806023182204. [DOI] [PubMed] [Google Scholar]
  38. Urowitz M. B., Gladman D. D., Tozman E. C., Goldsmith C. H. The lupus activity criteria count (LACC). J Rheumatol. 1984 Dec;11(6):783–787. [PubMed] [Google Scholar]
  39. Vogt A., Rohrbach R., Shimizu F., Takamiya H., Batsford S. Interaction of cationized antigen with rat glomerular basement membrane: in situ immune complex formation. Kidney Int. 1982 Jul;22(1):27–35. doi: 10.1038/ki.1982.128. [DOI] [PubMed] [Google Scholar]
  40. Webb J., Whaley K. Evaluation of the native DNA-binding assay for DNA antibodies in systemic lupus erythematosus and other connective tissue diseases. Med J Aust. 1974 Aug 31;2(9):324–328. doi: 10.5694/j.1326-5377.1974.tb70809.x. [DOI] [PubMed] [Google Scholar]
  41. Wells J. V., Webb J., Van Deventer M., Fry B., Pollard K. M., Raftos J., Monk W., Nelson D. S. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases. Clin Exp Immunol. 1979 Dec;38(3):424–435. [PMC free article] [PubMed] [Google Scholar]
  42. Wu R. S., Panusz H. T., Hatch C. L., Bonner W. M. Histones and their modifications. CRC Crit Rev Biochem. 1986;20(2):201–263. doi: 10.3109/10409238609083735. [DOI] [PubMed] [Google Scholar]
  43. Yokohari R., Tsunematsu T. Application, to Japanese patients, of the 1982 American Rheumatism Association revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1985 Jun;28(6):693–698. doi: 10.1002/art.1780280614. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES